Massachusetts HIV and Justice-Involved Populations Research Network
Project Number1R61DA060588-01
Contact PI/Project LeaderWURCEL, ALYSSE GAIL Other PIs
Awardee OrganizationTUFTS MEDICAL CENTER
Description
Abstract Text
PROJECT SUMMARY
A major driver of the U.S. HIV epidemic is inadequate access to HIV prevention and care in the criminal legal
system. The End HIV Epidemic (EHE) Toolkit recommends that jails offer low-barrier access to HIV testing,
treatment, and prevention to people who inject opioids, but many justice-involved people with opioid use
disorder (OUD) do not know their HIV status and few access medications to prevent HIV (pre-exposure
prophylaxis, PrEP). Suffolk County, the only EHE-designated jurisdiction in Massachusetts (MA), had a recent
HIV outbreak, occurring in formerly incarcerated people with OUD, that disproportionately impacted three
geographically and racially distinct communities (Boston, Chelsea, Revere). Improvements were made to
increase carceral HIV prevention and care, but one year into implementation only about 10% were HIV tested
and few were initiated on PrEP. MA Medicaid now authorizes coverage of HIV care before, upon, and following
release from incarceration, but HIV care is not well-integrated with the jails’ existing medications for opioid use
disorder (MOUD) program and there are gaps between jails and community healthcare. The Massachusetts
HIV/Justice Research Network proposes to partner with the Suffolk jail system and community treatment
partners to conduct a formative evaluation and pilot (R61, Aim 1) and type 2 hybrid implementation-
effectiveness study (R33, Aims 2-4) of a multi-pronged intervention to increase HIV testing and PrEP linkage
called ID-TOUCH (ID Testing OUtreach in Carceral Hubs). We will (1) Perform a formative evaluation of HIV
care gaps and opportunities in Suffolk jails, using (1a) stakeholder engagement to co-design ID-TOUCH, (1b)
existing administrative data to identify touchpoints for HIV care, focusing on differential barriers among
incarcerated people who were and were not treated with MOUD, and (1c) a pilot-trial of ID-TOUCH, measuring
changes in HIV testing, feasibility and acceptability, and self-reported patient outcomes. (2) Conduct a
longitudinal treatment outcome study comparing outcomes of individuals released from Suffolk jails (a) during
ID-TOUCH implementation, (b) before implementation, and (c) in relation to a nearby comparable jail system
(contemporaneous control site) using the MA Public Health Data Warehouse, a collection of two dozen linked
state administrative data sets, to examine HIV testing and post-release linkage to PrEP or HIV treatment. (3)
Conduct an implementation study of ID-TOUCH to understand contextual factors that facilitate and impede
delivery of HIV care in jail and community care coordination, and best practice strategies that optimize HIV
care. (4) Estimate the cost of implementing and sustaining ID-TOUCH, and assess its economic value, relative
to usual care, from healthcare sector, state-policymaker, and societal perspectives. The Massachusetts
HIV/Justice Research Network, with the MA Department of Public Health, Suffolk jails, and community
treatment partners, has the experience and expertise to fulfill the study aims. This study’s insights will inform
the development of new treatment options to end the HIV epidemic in jail populations.
Public Health Relevance Statement
PROJECT NARRATIVE
The Massachusetts HIV/Justice Research Network will develop and study the outcomes and implementation of
an intervention to increase access to carceral HIV healthcare. Findings will have implications for HIV treatment
and prevention to end the HIV epidemic in jail populations.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAddressAuthorization documentationBostonCaringCollectionCommunication MethodsCommunitiesCommunity HealthcareCommunity ServicesContinuity of Patient CareCountyDataData SetDevelopmentDiagnostic ServicesDisease OutbreaksEpidemicEventFoundationsFutureGeographyGoalsHIVHIV SeronegativityHealth Care CostsHealth Care SectorHealth StatusHealthcareHuman immunodeficiency virus testImprisonmentIndividualInfectionInterventionJailJusticeLegalLegal systemLinkLived experienceMassachusettsMeasuresMedicaidMethodsModalityModelingOpioidOutcomeOutcome MeasureOutcome StudyOverdosePatient Outcomes AssessmentsPatient Self-ReportPenetrationPersonsPharmaceutical PreparationsPhasePolicy MakerPopulationPopulation ResearchPreventionPublic HealthRaceRecommendationResearchResourcesSiteSystemTestingTreatment outcomeacceptability and feasibilitycare coordinationcommunity partnerscontextual factorscost effectivecost estimatedata warehousedesigneconomic valueeffectiveness/implementation studyexperienceformative assessmenthealth care serviceimplementation interventionimplementation studyimprovedinsightmedication for opioid use disordermortalityopioid use disorderoutreachoutreach programpilot testpilot trialpre-exposure prophylaxispreventprevention serviceprimary outcomeprocess improvementprogramspublic health relevancereincarcerationresponsesafety netsecondary outcomesuccesstreatment as usualtreatment servicesuptake
National Institute of Allergy and Infectious Diseases
$1,250,815
2024
National Institute on Drug Abuse
$21,937
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R61DA060588-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R61DA060588-01
Patents
No Patents information available for 1R61DA060588-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R61DA060588-01
Clinical Studies
No Clinical Studies information available for 1R61DA060588-01
News and More
Related News Releases
No news release information available for 1R61DA060588-01
History
No Historical information available for 1R61DA060588-01
Similar Projects
No Similar Projects information available for 1R61DA060588-01